ArticleThe Journal of clinical investigation2025

A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma.

Heejae Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.